Severe Acute Respiratory News and Research

RSS
Omicron subvariants BA.2.12.1, BA.4, and BA.5 show higher neutralization resistance to antibodies

Omicron subvariants BA.2.12.1, BA.4, and BA.5 show higher neutralization resistance to antibodies

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Study characterizes long-COVID symptoms in hospitalized and non-hospitalized COVID-19 patients

Study shows long COVID remodeling of T cell dynamics is dependent on SARS-CoV-2 severity

Study shows long COVID remodeling of T cell dynamics is dependent on SARS-CoV-2 severity

Age-specific susceptibility during the Omicron driven, Delta driven, and pre-Delta waves in South Korea

Age-specific susceptibility during the Omicron driven, Delta driven, and pre-Delta waves in South Korea

Effectiveness of Pfizer-BioNTech’s BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron variants among teens

Effectiveness of Pfizer-BioNTech’s BNT162b2 vaccine against SARS-CoV-2 Delta and Omicron variants among teens

The effects and mechanisms of SARS-CoV-2 on the nervous system

The effects and mechanisms of SARS-CoV-2 on the nervous system

The severity of Omicron BA.4/BA.5 lineages in the South Africa population

The severity of Omicron BA.4/BA.5 lineages in the South Africa population

Researchers investigate the possibility that SARS-CoV-2 can be transmitted by the wind

Researchers investigate the possibility that SARS-CoV-2 can be transmitted by the wind

A fast, highly sensitive, point-of-care RT-LAMP and CRISPR/Cas12a assay for the detection of SARS-CoV-2

A fast, highly sensitive, point-of-care RT-LAMP and CRISPR/Cas12a assay for the detection of SARS-CoV-2

South African study shows COVID severity of Omicron BA.1, BA.4, BA.5 all similar

South African study shows COVID severity of Omicron BA.1, BA.4, BA.5 all similar

Identification of potent SARS-CoV-2 macrodomain inhibitors

Identification of potent SARS-CoV-2 macrodomain inhibitors

Canada handled COVID well by most measures

Canada handled COVID well by most measures

How to develop an "all-variant" COVID vaccine

How to develop an "all-variant" COVID vaccine

Casirivimab/imdevimab improve outcomes in early COVID-19

Casirivimab/imdevimab improve outcomes in early COVID-19

SARS-CoV-2 3CLpro also susceptible to mutations

SARS-CoV-2 3CLpro also susceptible to mutations

Scientists report autoimmunity from molecular mimicry between SARS-CoV-2 spike and human proteins

Scientists report autoimmunity from molecular mimicry between SARS-CoV-2 spike and human proteins

Researchers explore disease severity post-infection with SARS-CoV-2 Omicron in hematologic patients

Researchers explore disease severity post-infection with SARS-CoV-2 Omicron in hematologic patients

The distribution and dynamics of microbial populations on surfaces within a clinical microbiology lab during the COVID-19 pandemic

The distribution and dynamics of microbial populations on surfaces within a clinical microbiology lab during the COVID-19 pandemic

Epigenome-wide DNA methylation patterns in convalescent COVID-19 subjects

Epigenome-wide DNA methylation patterns in convalescent COVID-19 subjects

Study finds Omicron variant could break through vaccine protection more effectively than the Delta variant

Study finds Omicron variant could break through vaccine protection more effectively than the Delta variant

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.